(Q81097337)
English
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less
scientific article published on 05 September 2007
Statements
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial (English)
Bernard J Gersh
Benjamin M Scirica
David A Morrow
Hanoch Hod
Luiz Belardinelli
Chester M Hedgepeth
Peter Molhoek
Freek W A Verheugt
Carolyn H McCabe
Eugene Braunwald
5 September 2007